In today’s session Monsanto Company (MON) recorded an unusually high (1,271) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the January, 2017 put, expecting serious MON decrease. With 1,271 contracts traded and 28694 open interest for the Jan, 17 contract, it seems this is a quite bearish bet. The option with symbol: MON170120P00100000 closed last at: $2.2 or 4.8% up. About 634,931 shares traded hands. Monsanto Company (NYSE:MON) has risen 13.58% since March 14, 2016 and is uptrending. It has outperformed by 7.97% the S&P500.
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 20 analysts covering Monsanto Company (NYSE:MON), 14 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 70% are positive. Monsanto Company has been the topic of 39 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The firm has “Buy” rating given on Thursday, September 15 by Deutsche Bank. Piper Jaffray maintained it with “Overweight” rating and $133 target price in Thursday, August 27 report. Citigroup maintained Monsanto Company (NYSE:MON) rating on Friday, July 1. Citigroup has “Neutral” rating and $112 price target. The stock of Monsanto Company (NYSE:MON) has “Neutral” rating given on Friday, August 19 by Citigroup. As per Thursday, October 6, the company rating was maintained by Barclays Capital. The firm earned “Neutral” rating on Wednesday, September 23 by Goldman Sachs. The firm earned “Sell” rating on Monday, April 11 by Goldman Sachs. Jefferies upgraded the shares of MON in a report on Wednesday, May 25 to “Buy” rating. The stock of Monsanto Company (NYSE:MON) earned “Neutral” rating by Citigroup on Thursday, April 7. JP Morgan upgraded the shares of MON in a report on Wednesday, September 21 to “Overweight” rating.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Insitutional Activity: The institutional sentiment increased to 0.91 in Q2 2016. Its up 0.10, from 0.81 in 2016Q1. The ratio increased, as 88 funds sold all Monsanto Company shares owned while 334 reduced positions. 142 funds bought stakes while 243 increased positions. They now own 338.57 million shares or 4.89% less from 355.97 million shares in 2016Q1.
Miles has 0.16% invested in the company for 2,216 shares. Ameriprise Fincl, a Minnesota-based fund reported 1.75 million shares. Fishman Jay A Ltd Mi last reported 0% of its portfolio in the stock. Bessemer Group has 0.01% invested in the company for 21,233 shares. Acadian Asset Management Limited Liability Com holds 1,204 shares or 0% of its portfolio. Addison Co, a Pennsylvania-based fund reported 17,050 shares. Hengehold Capital Mngmt Llc has invested 0.07% of its portfolio in Monsanto Company (NYSE:MON). Deere & holds 0.18% of its portfolio in Monsanto Company (NYSE:MON) for 31,502 shares. Prudential Public Ltd Llc reported 7,313 shares or 0% of all its holdings. Menta Capital Limited Liability Com last reported 3,000 shares in the company. Callahan Advsr Ltd holds 8,547 shares or 0.23% of its portfolio. Davidson And Garrard Inc has 0.11% invested in the company for 4,131 shares. Moreover, Pictet Asset Ltd has 0.14% invested in Monsanto Company (NYSE:MON) for 316,156 shares. Moreover, Pacad Limited has 0.27% invested in Monsanto Company (NYSE:MON) for 18,849 shares. Dekabank Deutsche Girozentrale holds 0.08% or 67,766 shares in its portfolio.
Insider Transactions: Since April 19, 2016, the stock had 1 insider purchase, and 2 insider sales for $7.90 million net activity. Shares for $361,319 were bought by MCMILLAN CHARLES S on Monday, October 10. FRALEY ROBERT T also sold $8.23 million worth of Monsanto Company (NYSE:MON) shares. MIZELL STEVEN also sold $31,958 worth of Monsanto Company (NYSE:MON) on Monday, October 10. Shares for $104,428 were sold by POSTE GEORGE on Tuesday, April 19.
Monsanto Company , along with its subsidiaries, is a well-known provider of agricultural products for farmers. The company has a market cap of $44.36 billion. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. It has a 33.84 P/E ratio. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
More important recent Monsanto Company (NYSE:MON) news were published by: Investorplace.com which released: “Monsanto Company’s Headwinds Make MON Stock a Tough Buy” on October 11, 2016, also Stltoday.com published article titled: “Monsanto’s smaller rivals see big opportunity as big companies combine”, 247Wallst.com published: “Insider Buying Slows as Earnings Season Heats Up: Lands’ End, Monsanto, AZZ …” on October 16, 2016. More interesting news about Monsanto Company (NYSE:MON) was released by: Businesswire.com and their article: “Monsanto Company Sets Webcast and Analyst/Media Call for Fourth Quarter and …” with publication date: September 28, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.